Diagnosis and surgical treatment of primary hepatic cholangiocarcinoma

Hepato-Gastroenterology

Volumn 52, Issue 62, 2005, Pages 348-351

  Han, Shao Liang ^a   Zhu, Guan Bao ^a   Yao, Jian Gao ^a   Lan, Sheng Hong ^a   Shao, Yong Fu ^b  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b Hospital of Cancer   (China)

Author keywords

Diagnosis; Liver neoplasm; Primary hepatic cholangiocarcinoma; Surgical resection; Treatment

Indexed keywords

ALPHA FETOPROTEIN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; DOXORUBICIN; FLUOROURACIL; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; MITOMYCIN C; TUMOR MARKER;

ABDOMINAL DISCOMFORT; ABDOMINAL MASS; ABDOMINAL PAIN; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT STONE; CANCER ADJUVANT THERAPY; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EARLY DIAGNOSIS; ECHOGRAPHY; FEMALE; HEPATITIS B; HUMAN; JAUNDICE; LAPAROTOMY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; LIVER SCINTISCANNING; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY HEPATIC CHOLANGIOCARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TUMOR BIOPSY;

CHEMOEMBOLIZATION, THERAPEUTIC; CHEMOTHERAPY, ADJUVANT; CHOLANGIOCARCINOMA; EARLY DIAGNOSIS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 16344367571     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kew MC: Tumors of the liver (Hepatic Tumor). In: Zakim D, Boyer TD (Eds.). Hepatology- A textbook of liver disease. 2nd Edition. W.B. Saunders company, 1990; pp. 1206-1240.
2. The Liver Cancer Study Group of Japan: Primary liver cancer in Japan. Clinicopathological features and results of surgical treatment. Ann Surg 1990; 211:277-287.
3. Altaee MY, Johnson PJ, Farrant JM, Willians R: Etiologic and clinical characteristics of peripheral and hilar - cholangiocarcinoma. Cancer 1991; 68:2051-2055.
4. Craig JR, Peters RL, Edmonson HA: Cholangiocarcinoma. In: Craig JR, Peters RL, Edmonson HA (Eds.). Tumors of the liver and intrahepatic bile ducts. Atlas of Tumor Pathology, fascicle 26. Washington, DC: Armed Force Institute of Pathology, 1989; pp. 197-211.
5. Shiraishi M, Hiroyasu S, Nagahama M, Tomita S, Miyahira T, Kusano T, et al: Characteristics of hepatocellular carcinoma in patients with negative virus markers: clinicopathologic study of resected tumors. World J Surg 1999; 23:301-305.
6. Miyagawa S, Kawasaki S, Makuuchi M: Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: tumor multicentricity in cirrhotic liver with hepatitis C. Hepatology 1996; 24:307-315.
7. Ikehata A, Ono S: A case of cholangiocellular carcinoma with production of alpha-fetoprotein. Jpn J Cancer Clin 2000; 46(2):142-146. (In Japanese with English abstract)
8. Berdah SV, Delpero JR, Garcia S, Hardwigsen J, LeTreut YP: A western surgical experience of peripheral cholangiocarcinoma. Br J Surg 1996; 83:1317-1521.
9. Lesurtel M, Regimbeau JM, Farges O, Colombat M, Sauvanet A, Belghiti J: Intrahepatic cholangiocarcinoma and hepatolithiasis: unusual association in Western countries. Eur J Gastroenterol Hepatol 2002; 14(9):1025-1027.
10. Kim YT, Byun JS, Kim J, Jang YH, Lee WJ, Ryu JK, Kim SW, Yoon YB, Kim CY: Factors predicting concurrent cholangiocarcinomas associated with hepatolithiasis. Hepatogastroenterology 2003; 50(49):8-12.
11. Kuroki T, Fukuda K, Yamanouchi K, Kitajima T, Matsuzaki S, Tajima Y, Furui J, Kanematsu T: Helicobacter pylori accelerates the biliary epithelial cell proliferation activity in hepatolithiasis. Hepatogastroenterology 2002; 49(45):648-651.
12. Kawarada Y, Mizumoto R: Diagnosis and treatment of cholangiocellular carcinoma of the liver. Hepatogastroenterology 1990; 37:176-181.
13. Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome M, Miyazaki M: Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 2002; 89(12):1525-1531.
14. Kusano T, Yasutake H, Miyashita T, Jibiki K, Akama M, Yamamoto N, et al: A study of cholangiocellular carcinoma of the peripheral type. Jpn J Cancer Clin 1993; 39(1):39-44.
15. Chen Y, Li H: Imaging findings of intrahepatic peripheral cholangiocarcinoma. Chin J Oncol 2000; 22(4):318-319. (In Chinese with English abstract)
16. Yoshida Y, Imai Y, Murakami T, Nishikawa M, Kurokawa M, Yonezawa T, et al: intrahepatic cholangiocarcinoma with marked hypervascularity. Abdom Imaging 1999, 24:66-68.
17. Tsuji M, Kashihara T, Terada N: An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with cytokeratin 18 and 19. Pathol Internat 1999; 49:310-317.
18. Isa T, Kusano T, Shimoji H, Takeshima Y, Muto Y, Furukawa M: Predictive factors for long-term survival in patients with intrahepatic cholangiocarcinoma. Am J Surg 2001; 181(6):507-511.
19. Kokudo N, Makuuchi M: Extent of resection and outcome after curative resection for intrahepatic cholangiocarcinoma. Surg Oncol Clin N Am 2002; 11(4):969-983.
20. Harrison LE, Fong Y, Klimstra DS, Zee SY, Blumgart LH: Surgical treatment of 32 patients with peripheral intrahepatic cholangiocarcinoma. Br J Surg 1998; 85:1068-1070.
21. Kinoshita H, Tanimura H, Uchiyama K, Tani M, Onishi H, Yamada H: Prognostic factors of intrahepatic cholangiocarcinoma after surgical treatment. Oncol Rep 2002; 9(1):97-101.
22. Nakajima T, Kondo Y, Miyazaki M, Okui K: A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and modes of spreading. Hum Pathol 1988; 19:1228-1234.
23. Yamamoto J, Kosuge T, Takayama T, Shimada K, Makuuchi M, Yoshida J, et al: Surgical treatment of intrahepatic cholangiocarcinoma: four patients surviving more than five years. Surgery 1992; 111:617-622.